Epigenetics Conference | Epigenetics 2019 | Epigenetics Congress | Cancer Conference | Biomarker Conferences | World Cancer Conference | ICEC 2019 | Molecular Biology conferences | Genetics Conference | Radiology Conferences | Genomics conference | CME Conference | Vienna | Austria | Europe | USA | Middle East

Theme: Global leading changes to advance Diagnosis & Precision medicine Cancer,Cardio,Reproductive,Diabetes,Surgery,Neuro,Healthcare,Pathology,Radiology

Epigenetics 2019

Scientific Program

Renowned Speakers

Diana Anderson
University of Bradford
UK

Michael Retsky
Harvard TH Chan School of Public Health
USA

Magnus S Magnusson
University of Iceland
Iceland

Sergey Suchkov
I M Sechenov First Moscow State Medical University
Russia

Massimo Bonucci
University of Chieti
Italy

Arshak R Alexanian
Cell Reprogramming & Therapeutics LLC
USA

Helieh S. Oz
UK Medical Center
USA

Olivier E Pardo
Imperial College London
UK

Mohamed Zeyad ElZawahry
Cairo University
Egypt

Manuela Stoicescu
University of Oradea
Romania

Suraiya Rasheed
University of Southern California
USA

Jenny Wang
University of New South Wales
Australia

Manal H Al Khanbashi
Higher College of Technology
Oman

Pedro Sanchez Rovira
Xanit International Hospital
Spain

David A Ligon
Oncology Fox LLC
USA

Atsushi Kaneda
Chiba University
Japan

Ladan Teimoori-Toolabi
Pasteur Institute of Iran
Iran

Sang Hyun Lee
Duke-NUS Medical School
Singapore

Epigenetics 2019

TRACK 1. Biochemical approaches of Epigenetics:

Biochemical mechanisms of Epigenetics DNA methylation, recognition of methylated CpG, demethylation in mammals, histone modifications, non-coding RNAs, microRNAs, the effect of chromosome organization, mechanisms of polycomb proteins.

Biochemical approaches to study Epigenetics Analysis of tissue-specific DNA methylation, methods for assessing genome-wide DNA methylation, methylation of Lysine-9 of Histone H3: role in heterochromatin modulation and tumorigenesis, chromatin modifications distinguish genomic features and physical organization of the nucleus, assessing epigenetic information

microRNAs
Combined Epigenetic Therapies
Epigenetic and Cytotoxic Therapies
DNA methylation
Post-translational histone modifications
Non-coding RNA

European Conference on Epigenetics, February 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA | Epigenetics and Chromatin, September, 11-15, 2018, Cold Spring Harbor, US | Transcription, Chromatin and Epigenetics, September, 16-21, 2018, Florence, IT | 5th Canadian Conference on Epigenetics, September, 30- October 03, 2018, Estérel, CA | Transcriptional Reg. by Chromatin and RNA Pol II, October, 04-07, 2018, Snowbird, US | Biological and Clinical Frontiers in Epigenetics, November, 06-10, 2018, Nassau, BS | Systems Epigenetics Towards Precision Cancer Medicine, November, 27-30, 2018, Amsterdam, ND | 2018 Max Planck Freiburg Epigenetics meeting, December, 05-07, 2018, Freiburg, DE | ICECT 2019 : 21st International Conference on Epigenetics, Chromatin and Transcription, January, 10-11, 2019, Singapore, SG

European Societies

USA Societies

Asian Societies

TRACK 2. Bioinformatics/ Computational Analysis of Epigenetics:

Epigenetics has emerged as a critical field for studying how non-gene factors can influence the traits and functions of an organism. At the core of this new wave of research is the use of computational tools that play crucial roles not only in directing the selection of key experiments, but also in formulating new testable hypotheses through detailed analysis of complex genomic information that is not achievable using traditional approaches alone without bioinformatics methods/tools.

Data sources for Epigenetic research
Computational tools for Epigenetic research
Cancer informatics
Stem cell informatics

Euro Oncology Summit, October 18-19, 2018, Amsterdam, Netherlands | 9th Euro Breast Cancer Summit, October 18-19, 2018, Amsterdam, Netherlands | 14th Global Biomarkers Summit, October 18-19, 2018, Amsterdam, Netherlands | 36th World Cancer Conference, October 11-13, 2018, Opfikon, Switzerland | International Conference on Robotic Oncology, October 26-27, 2018, Osaka, Japan | International Conference on Gastrointestinal Cancer and Therapeutics, October 29-30, 2018, San Francisco, California, USA | Transcription and RNA Regulation in Inflammation and Immunity, Febuary, 02-05, 2019, Tahoe City, US | Epigenetics and Human Disease, March, 17-21, 2019, Banff, CA | 3D Genome: Gene Regulation and Disease, March, 17-21, 2019, Banff, CA | How Alterations in DNA Sequence and Chromatin Modifications Impact Cancer Etiology and Therapy, April, 07-12, 2019, Lucca, IT | Chromatin and Epigenetics, EMBO Workshop, May, 01-04, 2019, Heidelberg, GE | Genetic, Molecular and Physical Views of Genomes and Their Organizational Principles, June, 23-28, 2019, Newry, ME, US

European Societies

USA Societies

Asian Societies

TRACK 3. Brain disorders & Epigenetics:

Neurodevelopmental disorders/diseases are a group of disorders in which the development of the central nervous system is disturbed. This can include brain dysfunction, which can manifest as neuropsychiatric problems or impaired motor function, learning, language or non-verbal communication.

This field of research provides evidence that environmentally induced epigenetic changes during embryonic development can be transmitted for multiple generations and may contribute to the etiology of brain disease heritability. In this review, we discuss some of the most updated findings on transgenerational epigenetic inheritance. We particularly discuss the upcoming findings on the epigenetic mechanisms involved in the heritability of alcohol-induced neurobehavioral disorders such as fetal alcohol spectrum disorders.

Therapeutic epigenetic-driven approaches to treat psychiatric disorders
Epigenetic link between psychiatric disorders and dementia
Epigenetic contributions to neurogenesis induction during ageing

26th Annual Congress on Cancer Science and Targeted Therapies, October 29-30, 2018, San Francisco, California, USA | International Conference on Frontiers in Lung Cancer, November 07-08, 2018, Singapore | International Conference on Biomarkers and Cancer Targets, December 5-6, 2018, Dubai, UAE | 2nd International Conference on Cancer Genetics and Epigenetics, November 12-13, 2018, Tokyo, Japan | 30th International Conference on Cancer Research and Therapy, November 12-13, 2018, Osaka, Japan | 30th Experts Meet On Cancer Therapy, November 14-15, 2018, Melbourne, Australia | 3rd Cancer Diagnostics & Treatment Conference, November 29-December 01 2018, Dublin, Ireland | 13th World Biomarkers Congress, November 29-30, 2018, Dublin, Ireland | 27th World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology, December 07-08, 2018, Chicago, Illinois, USA | The Eukaryotic Genome in 4 Dimensions: Integrative Approaches to Bridging Genotype and Phenotype, August, 04-09, 2019, Hong Kong, CN | Attacking Open Chromatin with ATAC Sequencing, 10 - 14 September, 2018, Heidelberg, Germany | 5th Canadian Conference on Epigenetics, 30 September-3 October, 2018, Estérel, Canada

European Societies

The Association for Cancer Surgery | Children's Cancer Association | Cyprus Anti Cancer Society | Belgian Association for Nurses in Radiotherapy and Oncology | Belgian Association of Oncological Radiotherapy | Belgian Oncology Pharmacy Practitioners | Belgium Foundation Against Cancer | Multicenter Italian Trias in Ovarian cancer and gynecologic malignancies | Finnish Society of Medical Genetics | Clinical Molecular Genetics Society | Austrian Group for Paediatric Haemato-Oncology

USA Societies

Asian Societies

TRACK 4. Cyto-epigenetic approaches:

Combining cytogenetic & epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients.

Cytogenetics is defined as the study of chromosomal structure, location and function in cells. Modern cytogenetic approaches are enable to label the chromosomal location of any gene using different colored dots, examine cells from any type of tissue (even tumor cells), identify cells that have lost or gained a specific chromosome & determine whether specific regions of chromosomes have been lost or gained without ever looking at the chromosomes under a microscope.

Cancer cytogenetics
Karyotyping
Fluorescent in situ hybridization
Cytotaxonomy
Molecular cytogenetics

8th World Conference on Women’s Health and Breast Cancer, December 17-18, 2018, Abu Dhabi, UAE | 32nd Euro Congress on Cancer Science & Therapy, March 07-08, 2019, Barcelona, Spain | 2nd World Conference on Medical Oncology & Haematology, Mar 27-28, 2019, Hong Kong | 2nd Global Meeting on Clinical Oncology and Radiology, Mar 27-28, 2019, Hong Kong | Epigenetics in the nervous system: development and disease, 1 - 3 October, 2018, Stockholm, Sweden | The Complex Life of RNA, 3 - 6 October, 2018, Heidelberg, Germany | RNA and genome maintenance: Cooperation and conflict management, 10 - 13 October, 2018, Mainz, Germany | From Epigenome Towards Epitranscriptome in Cell Fate Choice, 14 - 17 October, 2018, Capri, Italy | International Human Epigenome Consortium 2018, 26 - 28 October, 2018, Hong Kong, China | Society for Neuroscience 2018, 3 - 7 November, 2018, San Diego, USA | From Functional Genomics to Systems Biology, 10 - 13 November, 2018, Heidelberg, Germany | Conference Systems Epigenetics: Towards Precision Cancer Medicine, 27 - 30 November, 2018, Amsterdam, The Netherlands

European Societies

USA Societies

Asian Societies

TRACK 5. Cancer Epigenetics & Oncology:

Epigenetic modifications of the Cancer cell genome, which does not bring a change in the nucleotide sequence, is called Cancer Epigenetics.

Cancer was the first human disease to be linked to epigenetics. DNA hypomethylation can activate oncogenes and initiate chromosome instability, whereas DNA hypermethylationinitiates silencing of tumor suppressor genes. An accumulation of epigenetic & genetic errors can transform a normal cell into an invasive or metastatic tumor cell. DNA methylation patterns may cause abnormal expression of cancer-associated genes. Global histone modification patterns are also found to correlate with cancers such as breast, prostate, and pancreatic cancer.

Epigenetic modification are as important as genetic mutations in a cell's transformation to cancer, and their manipulation holds great promise for cancer prevention, detection, and therapy.

During the cell transformation to a cancerous cell, Epigenetic modifications are also crucial like genetic mutations. Their modification brings a great promising approach for prevention, detection, and therapy of Cancer.

Novel epigenetics targets in cancer
Histone variants and histone modifications
Cancer stem cells
Epigenetic tools and technologies
Epigenetic & Genetic aspects of breast cancer progression
Breast cancer risk and prevention

21st World Congress on Neonatal & Pediatric Oncology, April 1-2, 2019, Auckland, New Zealand | 23rd Global Annual Oncologists Meeting, April 04-05, 2019, Auckland, New Zealand | 3 rd World Congress on Radiology and Oncology, April 08-09, 2019, Abu Dhabi, UAE | 33rd Global Experts Meeting on Cancer Science & Therapy, April 29-30, 2019, Seoul, South Korea | 3rd Global Summit on Oncology & Cancer, May 6-7, 2019, Tokyo, Japan | 5th Max Planck Epigenetics Meeting, 5 - 7 December, 2018, Freiburg, Germany | Advances at the Interface Between Metabolism and Epigenetics, 16 - 17 January, 2019, Cambridge, United Kingdom | Chromatin and Epigenetics: Inheritance and Design, 1 - 3 April, 2019, Munich, Germany | Functions of Epitranscriptomes, 17 - 18 June, 2019, Chicago, USA | Epigenetic Mechanisms Across Scales: From Molecules to Environment and Evolution, July 21 - 26, 2019, Holderness, NH, US | Chromatin and Epigenetics, 1 - 4 May, 2019, Heidelberg, Germany

European Societies

USA Societies

Asian Societies

TRACK 6. Chromatin & its Dynamics:

Chromatin is subject to proofreading and repair mechanisms during replication and in response to DNA damage, ensuring the faithful inheritance of genetic and epigenetic information and maintaining genome stability.

Chromatin structure depends on several factors. The overall structure depends on the phase of the cell cycle. Human chromosomes can be divided into two type’s allosome & autosomes.

15th World Congress on Blood Cancer, May 09-10, 2019, Amsterdam, Netherlands | 2nd International conference on Cancer Science and Diagnostics, May 13-14, 2019, Osaka, Japan | 16th Asia Pacific Oncologists Annual Meeting, May 13-14, 2019, Singapore | 2nd International Conference on Oncodiagnostics and Cancer Research, June 17-18, 2019, Brisbane, Australia | 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25-27, 2019, London, UK | 26th Cancer Genomics Congress: New Era for Cancer Prevention, October 21-22, 2019, Abu Dhabi, UAE | 3rd Danube Conference on Epigenetics, 9-12 October 2018, Budapest, Hungary | 2nd Epigenetics and Bioengineering Conference (EpiBio 2018), October 4-6, 2018, San Francisco, CA | Epigenetics and Human Disease, March 17—21, 2019, Alberta, Canada | 3rd Annual Epigenetics Discovery Congress, 12 - 13, October, 2018 | Conference System Epigenetics: Towards Precision Cancer Medicine, 27 - 30, November, 2018, Amsterdam, The Netherlands

European Societies

USA Societies

Asian Societies

TRACK 7. Epigenetics:

Epigenetics is the study of heritable changes in gene expression (active versus inactive genes) i.e. an adjustment in phenotype without an adjustment in genotype. An epigenetic change is a natural & characteristic occurrence yet can likewise be affected by a few factors including age, the environment/lifestyle, and illness state. Alternately, epigenetic change can have all the more harmful impacts that can bring illnesses, disease. Major areas of Epigenetics are:

European Conference on Epigenetics, Febuary 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA Transcription and Chromatin, 25–28 August, Heidelberg, Germany | 22nd International Chromosome Conference, 02–05 Sept, Prague, Czech Republic | Principles of Chromosome Structure and Function, 05–08 Sept, Heidelberg, Germany | Epigenetics & Chromatin, 11–15 Sept, New York, US | ICECT 2018 : 20th International Conference on Epigenetics, Chromatin and Transcription, 13– 14 Sept, Osaka, Japan | Transcription, Chromatin, and Epigenetics, 16– 21 Sept, Florence, Italy | The 5th Canadian Conference on Epigenetics, 30–03 Oct, Quebec, Canada | Epigenetics in the nervous system: development and disease, 01–03 Oct 2018, Stockholm, Sweden

European Societies

USA Societies

Asian Societies

TRACK 8. Epigenetics in Biotechnology & Developmental Biology:

Epigenetic inheritance plays a vital role in many biological processes, such as gene expression in early embryo development, imprinting and the silencing of transposons. It has been established that epigenetic effects can be inherited from one generation to the next. Here, we review examples of epigenetic mechanisms governing animal phenotype and behaviour, and we discuss the importance of these findings in respect to animal studies, improve breeding, & the genetics of livestock. Through:

Chromatin remodelling
Epigenetics in tissue engineering
Production of recombinant proteins in human cells

Euro Oncology Summit, October 18-19, 2018, Amsterdam, Netherlands | 9th Euro Breast Cancer Summit, October 18-19, 2018, Amsterdam, Netherlands | 14th Global Biomarkers Summit, October 18-19, 2018, Amsterdam, Netherlands | 36th World Cancer Conference, October 11-13, 2018, Opfikon, Switzerland | The Complex Life of RNA, 03–06 Oct, Heidelberg, Germany | 2nd Epigenetics and Bioengineering Conference (EpiBio 2018), 04–06 Oct, San Francisco, US | 3rd Danube Conference on Epigenetics, 09–12 Oct, Budapest, Hungary | RNA and genome maintenance: Cooperation and conflict management, 10–13 Oct, Mainz, Germany | From epigenome towards epitranscriptome in cell fate choice, 14–17 Oct, Capri, Italy | RNA Biology, Suzhou, China | IMB Workshop: Molecular Mechanisms of Circadian Clocks, 15–16 Nov, 2018 | Systems Epigenetics: Towards Precision Cancer Medicine, 27–30 Nov, 2018, Amsterdam, The Netherlands | DNA Replication and Genome Instability: From Mechanism to Disease, 13–17 Jan, 2018, Utah, US

European Societies

USA Societies

Asian Societies

TRACK 9. Environmental Epigenetic Factor:

By the end of the last century, it was known that DNA by itself does not determine all characteristics of an organism, including humans. The environment, stress one perceives, and nutrition, to name a few, play a vital part in determining the response of an organism, as much as the DNA itself. Thus, it is known now that both nature (genetic makeup) and nurture (environmental factors) play equally important roles in the responses observed, both at the cellular and organism levels. Thus, humans are affected by both genetic and epigenetic factors.

Some environmentally induced changes in the epigenome are recorded in genomic DNA methylation patterns for up to three generations.

Certain stages in development and cell types can be thought of as particularly sensitive to epigenetic change due to the resulting severity of the outcome for the individual or the potential for affecting multiple generations.

Early life: Early embryo and germ line development can be affected by in utero exposures.
Gametogenesis and pre-conception: environmental exposures to oocytes and spermatozoa that go onto produce an embryo (pre-conception exposures) are also an important consideration
Somatic versus germ cell change: If an epigenetic change occurs in a somatic cell or in a germ cell that is correctly ‘reset’ during germ line development in the subsequent offspring.

Observations demonstrate that the environmental toxicants examined induced transgenerational ovarian adult-onset disease, and of spermatogenic cell defects and testis disease.

Transgenerational Ovarian Disease
Transgenerational Granulosa Cell Transcriptome
Transgenerational Granulosa Cell Epigenome
Transgenerational Spermatogenic Cell Abnormality
Sertoli Cell Transgenerational Transcriptome
Sertoli Cell Transgenerational Epigenome

26th Annual Congress on Cancer Science and Targeted Therapies, October 29-30, 2018, San Francisco, California, USA | International Conference on Frontiers in Lung Cancer, November 07-08, 2018, Singapore | International Conference on Biomarkers and Cancer Targets, December 5-6, 2018, Dubai, UAE | 2nd International Conference on Cancer Genetics and Epigenetics, November 12-13, 2018, Tokyo, Japan | Advances at the interface between metabolism and epigenetics, 16–17 Jan, 2019, Cambridge, UK | Transcription and RNA Regulation in Inflammation and Immunity, 02–05 Feb, 2019, California, US | Long Non-Coding RNAs: From Molecular Mechanism to Functional Genetics, 24–28 Feb, 2019, British Columbia, Canada | Chromatin and Epigenetics: Inheritance and Design, 01-03 April 2019, Munich, Germany | Epigenetics and Human Disease, 17–21 Mar, 2019, Hong Kong, China | Functions of Epitranscriptomes, 17–18 June 2019, Chicago, US| Epigenetics, 20–21 July, 2019, New Hampshire, US | 5th Canadian Conference on Epigenetics, 30 September-3 October, 2018, Estérel, Canada

European Societies

Cancer Nurses Society of Australia | Australasian Association of Cancer Registries | Australasian Lung Cancer Trials Group | Australian and New Zealand Children's Haematology/Oncology Group | Medical Oncology Group of Australia | Australian Association of Smoking Cessation Professionals | Australian Capital Territory Cancer Registry | Australian Cervical Cancer Foundation | Society of Pediatric Oncology and Hematology

USA Societies

Asian Societies

TRACK 10. Epigenetics Market Products & Instrumentation:

Instruments used in epigenetics are:

Mass Spectrometers
Next-generation Sequencers
qPCRs
Sonicators

Epigenetics Products are:

Enzymes (DNA Polymerases , DNA Ligases, Other DNA-modifying Enzymes)
Kits & Assays (Bisulfite Conversion Kits, Immunoprecipitation Kits , Chip-Seq Kits, Deep Sequencing Kits, Methyltransferase Assays, Histone Assays)
Reagents (Buffers, Histones, Antibodies, Magnetic Beads, Primers, and Other Epigenetics Reagents)

8th World Conference on Women’s Health and Breast Cancer, December 17-18, 2018, Abu Dhabi, UAE | 32nd Euro Congress on Cancer Science & Therapy, March 07-08, 2019, Barcelona, Spain | 2nd World Conference on Medical Oncology & Haematology, Mar 27-28, 2019, Hong Kong | 2nd Global Meeting on Clinical Oncology and Radiology, Mar 27-28, 2019, Hong Kong | 6th Cambridge International Stem Cell Symposium, 19 September 2018, Cambridge, United Kingdom | From Stem Cells to Human Development, 1 October, 2018, United Kingdom | 5th Canadian Conference on Epigenetics, 3 October, 2018, Estérel, Canada | Epigenetics in the nervous system: development and disease, 4 October, 2018, Stockholm, Sweden | The Complex Life of RNA, 10th October, 2018, Heidelberg, Germany | 2nd Epigenetics and Bioengineering Conference, 14^thOctober, San Francisco, USA | RNA and genome maintenance: Cooperation and conflict management, 26^thOctober, 2018, Mainz, Germany | From Epigenome Towards Epitranscriptome in Cell Fate Choice, 3 November, 2018, Capri,Italy

European Societies

USA Societies

Asian Societies

TRACK 11. Epigenetics in Pharmacology & Drug Discovery:

This field is concerned with the pharmacology of epigenetics to treat disorders of the epigenome whether induced developmentally or manifested/acquired later in life. In this particular conference, we will focus on brain disorders and their treatment by drugs that modify the epigenome.

Complexity of the epigenome
HDAC inhibitors
Anthracyclines

21st World Congress on Neonatal & Pediatric Oncology, April 1-2, 2019, Auckland, New Zealand | 23rd Global Annual Oncologists Meeting, April 04-05, 2019, Auckland, New Zealand | 3 rd World Congress on Radiology and Oncology, April 08-09, 2019, Abu Dhabi, UAE | 33rd Global Experts Meeting on Cancer Science & Therapy, April 29-30, 2019, Seoul, South Korea | International Human Epigenome Consortium 2018, October 26 th 2018, Hong Kong, China | Society for Neuroscience 2018, 3rd November, 2018, San Diego, USA| From Functional Genomics to Systems Biology, 10^th November, 2018, Germany | Conference Systems Epigenetics: Towards Precision Cancer Medicine, 27^th November, 2019, Amsterdam, The Netherlands | American Society of Hematology, 30^th November, 2018, San Diego, USA | 5th Max Planck Epigenetics Meeting, December 15th 2019, Freiburg im Breisgau, Germany | Advances at the Interface Between Metabolism and Epigenetics, 16^thJanuary, 2019, Cambridge, United Kingdom

European Societies

USA Societies

Asian Societies

TRACK 12. Epigenetics in reproductive health:

A range of epigenetic idea affect our genetic programme. The inter-generational transmission of epigenetic marks is supossed to operate via four principal means that dramatically differ in their information content: DNA methylation, histone modifications, microRNAs and nucleosome positioning.

Role in gametogenesis
Role in embryogenesis
Role in infertility
Role in assisted reproductive technology
Transgenerational epigenetic inheritance

European Conference on Epigenetics, Febuary 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA | Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture, March, 17^th 2019, Heidelberg, Germany | Transgenic Animals – Micromanipulation Techniques, March, 27th 2019, Heidelberg, Germany| Chromatin and Epigenetics: Inheritance and Design, 1^st April 2019, Munich, Germany | Chromatin and Epigenetics, May, 1st, 2019, Heidelberg, Germany | Functions of Epitranscriptomes, June, 17^th , 2019, Chicago, USA | Epigenetic Inheritance: Impact for Biology and Society, August, 26th, 2019, Zürich, Switzerland

European Societies

USA Societies

Asian Societies

TRACK 13. Epigenetics in Nervous System:

It is the study of the interaction between epigenetic process, which regulates gene expression without changing the deoxyribonucleic acid sequence, and the development, physiology and functions of the nervous system.

Histone Modifications in the Nervous System
Neurological disorders
Mania (Bipolar disorder)
Brain Disorders

European Conference on Epigenetics, Febuary 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA | Epigenetics and Chromatin, September, 11-15, 2018, Cold Spring Harbor, US | Transcription, Chromatin and Epigenetics, September, 16-21, 2018, Florence, IT | 5th Canadian Conference on Epigenetics, September, 30- October 03, 2018, Estérel, CA | Transcriptional Reg. by Chromatin and RNA Pol II, October, 04-07, 2018, Snowbird, US | Biological and Clinical Frontiers in Epigenetics, November, 06-10, 2018, Nassau, BS | Systems Epigenetics Towards Precision Cancer Medicine, November, 27-30, 2018, Amsterdam, ND | 2018 Max Planck Freiburg Epigenetics meeting, December, 05-07, 2018, Freiburg, DE | ICECT 2019 : 21st International Conference on Epigenetics, Chromatin and Transcription, January, 10-11, 2019, Singapore, SG

European Societies

USA Societies

Asian Societies

TRACK 14. Epigenetics in Cardiovascular Disease:

Epigenetics has been initially studied in patients with CVD for its prominent role in inflammation and vascular involvement Furthermore, epigenetic studies in cardiovascular medicine revealed a significant number of modifications affecting the development and progression of CVD. Epigenomics are involved in cardiovascular risk factors such as smoking, diabetes, hypertension and age.

Cardiac hypertrophy
Heart failure
Arrhythmias

European Societies

USA Societies

Asian Societies

TRACK 15. Epigenetics in Clinical Practice:

Clinical epigenetics is the application of molecular biology techniques detecting alterations in DNA methylation or histone modification to diagnose or study disorders characterized by heritable defects in the expression of a gene or genome.

Biologic predictors of response to epigenetic therapy

European Societies

USA Societies

The Oncology Society of New Jersey | Association for International Cancer Research | Association for Multiple Endocrine Neoplasia Disorders | Association for the Study of Lung Cancer | Association of Cancer Online Resources | International Academy of Oral Oncology | International Association of Cancer Registries | American Human Geneticists of Indian Subcontinent Origin

Asian Societies

Philippine Radiation Oncology Society | Philippine Society of Pediatric Oncologists | Philippine Society of Hematology & Blood Transfusion | Philippine Society of Medical Oncologists | Philippine College of Surgeons and its member societies | Saudi Cancer Society

TRACK 16. Genetics & Epigenetic inheritance:

Genetics generally considered a field of biology deals with the study of genes, genetic variation & heredity in living organisms.

Epigenetic inheritance is an unconventional finding. It means that a parent experiences, in the form of epigenetic tags, can be passed down to future generations. It goes against the idea that inheritance happens only through the DNA code that passes from parent to offspring.

Epigenetic mark

A genetic disorder is a genetic problem caused by one or more abnormalities in the genome, especially a condition that is present from birth.

Genetic alteration of the epigenome therefore contributes to cancer just as epigenetic process can cause point mutations and disable DNA repair functions. This crosstalk between the genome and the epigenome offers new possibilities for therapy.

European Societies

USA Societies

Asian Societies

TRACK 17. Genomics and Epigenetics Division:

The study of epigenomics involves genome-wide mapping of DNA methylation, histone modifications, nucleosome positioning and three-dimensional architecture and the integration of this information with RNA expression to understand the complexity of cell biology and development. Visualisation of these complex data sets is key for interpretation and deciphering the underlying biology associated with genetic and epigenetic variation.

The Genomics and Epigenetics Division incorporates 4 core strengths to address Genome Biology and Disease:

High Throughput Sequencing Technology
Genomic and Epigenetic Technology Development
Bioinformatics Tools for Integrative Analysis
Visualisation of Genome and Epigenome data sets

European Societies

Portuguese Cancer League | Romanian Cancer League | Romanian Society for Radiotherapy and Medical Oncology | Royal Australasian College of Surgeons - Surgical Oncology Section | Scientific Association of Swiss Radiation Oncology | Serbian Society for the Fight Against Cancer | Austrian Society of Human Genetics | Cancer Epigenetics Society | Romanian Society of Paediatric Haematology-Oncology

USA Societies

International Myeloma Foundation | International Society for Gastrointestinal Hereditary Tumours | International Society of Nurses in Cancer Care | International Society of Ocular Oncology | International Society of Oncology Pharmacy Practitioners | International Society of Pediatric Oncology | The Michigan Society of Hematology and Oncology (MSHO)

Asian Societies

TRACK 18. Immunology in the epigenetic era:

There are several evidence showing that loss of epigenetic control over complex immune processes contributes to autoimmune disease. Abnormal DNA methylation has been observed in patients with lupus whose T cells exhibit decreased DNA methyltransferase activity & hypomethylated DNA. Disregulation of this pathway apparently leads to overexpression of methylation-sensitive genes such as the leukocyte function-associated factor (LFA1), which causes lupus-like autoimmunity.

Systemic lupus erythematosus
Rheumatoid arthritis
Systemic sclerosis
Sjogren’s syndrome
Autoimmune thyroid diseases (AITD)

European Conference on Epigenetics, Febuary 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA | Epigenetics and Chromatin, September, 11-15, 2018, Cold Spring Harbor, US | Transcription, Chromatin and Epigenetics, September, 16-21, 2018, Florence, IT | 5th Canadian Conference on Epigenetics, September, 30- October 03, 2018, Estérel, CA | Transcriptional Reg. by Chromatin and RNA Pol II, October, 04-07, 2018, Snowbird, US | Biological and Clinical Frontiers in Epigenetics, November, 06-10, 2018, Nassau, BS | Systems Epigenetics Towards Precision Cancer Medicine, November, 27-30, 2018, Amsterdam, ND | 2018 Max Planck Freiburg Epigenetics meeting, December, 05-07, 2018, Freiburg, DE | ICECT 2019 : 21st International Conference on Epigenetics, Chromatin and Transcription, January, 10-11, 2019, Singapore, SG

European Societies

USA Societies

International Thoracic Oncology Nursing Forum | International Waldenstrom's Macroglobulinemia Foundation | International Workshop on Multiple Endocrine Neoplasia | Association of Oncology Social Work | Association of Pediatric Hematology / Oncology Nurses | Avon Breast Cancer Crusade | Leukemia & Lymphoma Society

Asian Societies

TRACK 19. Microbial Epigenetics:

Studies highlight that bacteria can affect the chromatin structure and transcriptional program of host cells by influencing diverse epigenetic factors. Bacterial & Viral infections are involved in the development of human cancers, such as liver, cervical, head and neck, nasopharyngeal and gastric cancers.

DNA methylation affects many biological processes in microbes and may play a role in pathogenicity and virulence. Characterizing methyltransferase & DNA methylation specificities is now possible during long-read sequencing.

European Societies

Estonian Society of Human Genetics | French Association of Genetic Counsellors (AFCG) | French Federation of Human Genetics | Genetic Association in Bosnia and Herzegovina (UdruÅ¾enje geneticara u BiH – GENUBIH) | Georgian Society of Medical Genetics and Epigenetics | German Society of Human Genetics | Slovak Pediatric Association – Section of Paediatric Haemato-Oncology

USA Societies

Asian Societies

TRACK 20. Medical Epigenetics:

This field provides a comprehensive analysis of the importance of epigenetics to health management.

In several diseases, including all cancers, the epigenetic control of the genome is heavily distorted. Measuring these alterations provides a detailed picture of the disease-specific changes, which is often informative for distinguishing disease subtypes or identifying suitable treatments. Therefore, epigenetics has much to offer for improving disease treatment choice & diagnosis.

Coverage of emerging topics including:

Epigenetics of gastrointestinal disease
Muscle disorders
Endocrine disorders
Ocular medicine
Pediatric diseases
Sports medicine
Noncoding RNA therapeutics
Pain management
Regenerative medicine

European Societies

USA Societies

Asian Societies

TRACK 21. Need of Epigenetic Biomarkers:

The epigenome describes to the complete description of all potentially heritable modifications of the genome without any changes in primary DNA sequences. Epigenetic biomarkers can be widely defined as measurable modifications of the genome with preserved DNA sequence.

Epigenetic manupulation and regulators represent potential molecular elements which control relevant physiological and pathological features, thereby contributing to the natural history of human disease. These epigenetic modulators can be used as disease biomarkers, since they show several advantages and provide information about gene function, thus explaining differences among patient endophenotypes.

Noninvasive Epigenetic Markers can be used as biomarkers for the molecular diagnosis of following cancer:

European Societies

USA Societies

Asian Societies

TRACK 22. Plant Epigenetics:

Plants are masters of epigenetic regulation. All of the major epigenetic mechanisms known to occur in eukaryotes are used by plants, with the responsible pathways elaborated to a degree that is unsurpassed in other taxa. The study of epigenetics in plants has a long and rich history, from initial descriptions of non-Mendelian gene behaviors to seminal discoveries of chromatin-modifying proteins and RNAs that mediate gene silencing in most eukaryotes, including humans.

Unlike animals, plants stably inherit their DNA methylomes from one generation to the next. The resulting gene silencing likely hides an abundance of phenotypic variation.

Methylation inheritance
Reprogramming exceptions
Improving agriculture

European Societies

USA Societies

Asian Societies

TRACK 23. Toxicoepigenetics:

The epigenome is responsive to a wide range of environmental factors, including toxicant exposure, diet, stress, and socioeconomic circumstances. Traditional toxicological paradigms have relied on factors such as age, genetic polymorphisms, and disease status to identify variability in responsiveness to environmental toxicant exposure; however, these factors are neither sufficient to faithfully identify differentially responsive individuals, nor are they modifiable factors that can be leveraged to mitigate adverse health effects of toxicant exposures. An individual's epigenome, on the other hand, can be shaped by interactions with chemical and nonchemical aspects of the environment, giving it potential as a tool for the promotion of public health. The field of toxicoepigenetics is fastly evolving to provide novel insights into the mechanisms underlying exposureâ€related susceptibility and disease.

European Conference on Epigenetics, Febuary 25-26, 2019, Paris, France| Annual Epigenetics Conference, November 28-29, 2018, Tokyo, Japan | 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics, October 03-04, 2018, Los Angeles, California, USA | 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery, October 03-04, 2018, Los Angeles, California, USA | Epigenetics and Chromatin, September, 11-15, 2018, Cold Spring Harbor, US | Transcription, Chromatin and Epigenetics, September, 16-21, 2018, Florence, IT | 5th Canadian Conference on Epigenetics, September, 30- October 03, 2018, Estérel, CA | Transcriptional Reg. by Chromatin and RNA Pol II, October, 04-07, 2018, Snowbird, US | Biological and Clinical Frontiers in Epigenetics, November, 06-10, 2018, Nassau, BS | Systems Epigenetics Towards Precision Cancer Medicine, November, 27-30, 2018, Amsterdam, ND | 2018 Max Planck Freiburg Epigenetics meeting, December, 05-07, 2018, Freiburg, DE | ICECT 2019 : 21st International Conference on Epigenetics, Chromatin and Transcription, January, 10-11, 2019, Singapore, SG

European Societies

USA Societies

Asian Societies

Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.

Join the 5^thInternational Congress on Epigenetics & Chromatin at Vienna, Austria during August 22-23, 2019

Theme: Epigenetics: Global leading changes to advance Diagnosis & Precision medicine

Cancer, Cardio, Reproductive, Diabetes, Surgery, Neuroscience, Healthcare, Pathology, Radiology

Epigenetics 2019 invites all the participants on behalf of organizing committee from all over the world to attend "5th International Congress on Epigenetics & Chromatin " which includes prompt keynote presentations, oral seminars, poster presentations and exhibitions.

Objective

The principal objective of this conference is to provide an international plateform for cutting edge research in chromatin and epigenetics.

The encompassing goal of this conference is to cover chromatin regulation, chromatin dynamics, signaling to chromatin, nuclear architecture and dynamics, developmental epigenetics, epigenomics, epigenetics and human diseases, genome stability, environmental epigenetics, Tran’s generational inheritance, functional genomics, system biology and super resolution microscopy.

Our aim is to provide Cancer Surgeons, Oncologists, Young researchers, Students, industrial delegates and anyone professionally involved in study of Epigenetics, Oncology, Genetics and Radiology and Imaging with an opportunity to learn about the complexity of the disease, discuss interventional procedures, look at new and advanced epigenetic practices and their efficiency and efficacy in the treatment of various Diseases and tumour extraction, and understand local realities and practical constraints in improving health-care.

About Organizers

Conference has an enhanced features of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research across the world through live streaming, B2B and Scientific Meetings. Medical Conferences provides an excellent opportunity for the emerging scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster (for more information visit Epigenetics 2019).

We Organize 300+ Scientific Conferences every year across Europe, USA & Asia. Besides 500 Peer reviewed, Open Access Journals, Conference series LLC LTD has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care and technologies. These journals are in the support of over 5 million readers; a team of 30,000 eminent scholars are providing editorial support.

Target Audience/who should attend?

Directors, Group Leaders, Heads, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from, Doctors, Medical Scientist, Cancer Researchers, Oncologists

Pharmaceutical, Bio-pharmaceutical and Research Institutes working in

· Epigenetics

· Developmental Epigenetics

· Epidemiology

· Biology

· Molecular Biology

· Developmental Biology

· Biomedical Sciences

· Biological Sciences

· Biochemistry

· Medicinal Chemistry

· Medicine

· Genetics and Genomics

· Developmental Genetics

· Organic Chemistry

· Natural Sciences

· Translational sciences/medicines

Who Should Sponsor

· Epigenetic Kits

. Bisulfite Conversion Kits

. ChIP-seq Kits

. RNA Sequencing Kits

. Whole Genome Amplification Kits

. 5-hmC and 5-mC Analysis Kits

· Epigenetic Enzymes

. DNA/Protein/RNA modifying Enzymes

· Epigenetic Instruments

. Genome Sequencing

. Next Generation Sequencing

. Single strand Sequencing

. Peptide arrays

· Epigenetic Reagents

. Antibodies

. Buffers

. Histones

. Magnetic Beads

. Primers

Glance at the Market

The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2018, at a CAGR of 13.5% during the forecast period. The growth in this market is primarily driven by the decreasing sequencing costs, increase in research activities, favorable government funding for epigenetics research, and rising prevalence of cancer.

High dominance of growth; expanding R and D financing; expanding force of examination exercises; expanding application for non-oncology sicknesses; and developing association between scholarly, biotechnology and pharmaceutical organizations are driving components of the epigenetics market.

cs.

On the basis of application, the market is bifurcated into oncology and non-oncology. Oncology is further sub-segmented into solid tumors & liquid tumors and non-oncology is further categorized into inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications. On the basis of end user, the market is classified into academic & research institutes, pharmaceutical companies, biotechnology companies & contract research organizations (CROs). Geographically, the market is analysed across Europe, North America, Asia-Pacific, and LAMEA.

Global Epigenetics Market was valued at $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023.

Figure: Epigenetics Market, by Geography, 2016-2023

In view of geology, the business sector of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into U.S. also, Canada.

The real players in the worldwide epigenetics business sector are Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), Merck and Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.)

Global Epigenetics Market, by Research Areas

· Developmental Biology

· Drug Discovery

· Oncology

· Other Epigenetics Research Areas

Glance at the Market

· North America was seen to be the biggest territorial epigenetics market representing more than 38.0% of the general income, because of components, for example, the expanding tumour commonness, expanding measure of financing for R&D, developing coordinated efforts between major pharmaceutical firms for advancement of enhanced therapeutics, high patient mindfulness levels.

· The Asia Pacific business sector is evaluated to witness development over the gauge time frame inferable from, the nearness of substantial pervasiveness of target maladies and high unmet medicinal necessities

· Some key players of the epigenetics market incorporate, Abcam, Illumina, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation, Oncolys Biopharma Inc.

· Extensive R&D activities went for the advancement of novel medications and the nearness of solid item pipeline is relied upon to further help market development over the gauge time frame.

Grand View Research has fragmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

· Reagents

· Kits

· Instruments

· Enzymes

· Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

· DNA Methylation

· Histone Methylation

· Histone Acetylation

· Large noncoding RNA

· MicroRNA Modification

· Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

· Oncology

· Solid Tumors

· Liquid Tumors

· Non Oncology

· Inflammatory Diseases

· Metabolic Diseases

· Infectious Diseases

· Cardiovascular Diseases

Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)

· North America

· U.S.

· Canada

· Europe

· UK

· Germany

· Asia Pacific

· Japan

· China

· India

· Latin America

· Brazil

· Mexico

· Middle East and Africa (MEA)

· South Africa

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 22-23, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View